Physician

Calvin Einar Mein, M.D.

According to 2025 Medicare claims, Calvin Mein, M.D. (NPI: 1164487617) practices ophthalmology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1619135647; TIN: 74-2109903) and primary practice location at 78624-5022.

Mein's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 902 traditional Medicare patients, billed 31,063 HCPCS/CPT codes, and received $3,441,434 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 582 prescription claims across 194 beneficiaries totaling $53,347 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 88 records totaling $191,226. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $23,779 to $53,347. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.7M$3.4M2015 Medicare payment: $2,261,426 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,355,983 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,191,533 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,673,498 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,719,388 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,906,544 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,995,600 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,020,777 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,576,995 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,441,434 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201599111,023$2,261,426
20161,09612,017$2,355,983
20171,09711,278$2,191,533
20187838,586$1,673,498
20197858,510$1,719,388
20206938,655$1,906,544
20217919,039$1,995,600
202278710,522$2,020,777
202389118,802$2,576,995
202490231,063$3,441,434

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$27K$53K2015 Drug cost: $23,779 (USD; Tot_Drug_Cst)2016 Drug cost: $23,852 (USD; Tot_Drug_Cst)2017 Drug cost: $39,925 (USD; Tot_Drug_Cst)2018 Drug cost: $47,010 (USD; Tot_Drug_Cst)2019 Drug cost: $52,874 (USD; Tot_Drug_Cst)2020 Drug cost: $47,150 (USD; Tot_Drug_Cst)2021 Drug cost: $27,175 (USD; Tot_Drug_Cst)2022 Drug cost: $32,772 (USD; Tot_Drug_Cst)2023 Drug cost: $26,852 (USD; Tot_Drug_Cst)2024 Drug cost: $53,347 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015112294$23,779
2016128327$23,852
2017129318$39,925
2018110319$47,010
2019106294$52,874
2020114320$47,150
2021114314$27,175
2022122382$32,772
2023134430$26,852
2024194582$53,347

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1711,654$656
67028Injection of drug into eye3681,571$100
92014Established patient complete exam of visual system584942$88
92134Imaging of retina7122,177$30
92250Photography of the retina377491$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium471,207$5,403
DifluprednateDifluprednate491,710$4,712
Prednisolone AcetatePrednisolone Acetate1295,425$4,466
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat1018,656$1,717
LatanoprostLatanoprost372,012$791

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.19$1,271Regeneron Pharmaceuticals, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.69$189,955Apellis Pharmaceuticals, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Calvin Einar Mein, M.D.?

Tedicare shows public-source Medicare data for Calvin Einar Mein, M.D. (NPI 1164487617), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Calvin Einar Mein, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Calvin Einar Mein, M.D.?

Calvin Einar Mein, M.D. is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1619135647) in the available physician profile data.

Does Calvin Einar Mein, M.D. have Open Payments data?

Calvin Einar Mein, M.D. has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.